
About Dongsung Bio Pharm
Dongsung Bio Pharm is a publicly listed company based in Seoul (South Korea) founded in 1957. Pharmaceuticals, cosmetics, and hair care products are manufactured. Its chief executive, as recorded, is Lee Yang Gu. Its website dongsung-pharm.com draws about 23 thousand monthly visits. Dongsung Bio Pharm offers products and services including Web Hosting and Domain Management. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Gabia, Inc.
Company details
Dongsung Bio Pharm was established in 1957 in Seoul, South Korea, within the pharmaceuticals and consumer goods sector. A range of over-the-counter and prescription medications is produced, alongside cosmetics, hair dyes, styling products, and health supplements. Various consumer items are also manufactured. Operations emphasize adherence to rigorous quality control standards across all production processes.
- Headquarters Seoul, South Korea
- Stage Public
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website dongsung-pharm.com
- Social Facebook
- Legal Name Dongsung Pharmaceutical Co., Ltd.
- Annual Revenue$60.36 M (USD)-1.45as on Dec 31, 2025
- Net Profit-$17.82 M (USD)-76.62as on Dec 31, 2025
- EBITDA-$14.35 M (USD)-73.91as on Dec 31, 2025
Products & Services of Dongsung Bio Pharm
Dongsung Bio Pharm offers a comprehensive portfolio of products and services, including Web Hosting and Domain Management.
Web hosting services are provided for websites and applications to ensure reliable online presence
Domain management services are offered for registration and connection to support seamless website operations
People of Dongsung Bio Pharm
1 people are tracked at Dongsung Bio Pharm (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lee Yang Gu | CEO | Leadership |
Complete people profiles for Dongsung Bio Pharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Dongsung Bio Pharm
Dongsung Bio Pharm is a publicly listed company on the KRX with ticker symbol 002210 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date19 Jan 1990
- Listed onKRX: 002210
- Listed entityDongsung Pharmaceutical Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7002210003
- Share price1,248.00 KRW (+3.57% on the day) · 2026-10-14
- Market capitalisation113,762,068,634.00 KRW
- EPS (diluted, trailing year)-293.15 KRW
- Volume (last session)31,982
Financials of Dongsung Bio Pharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 87.17B KRW | -25.74B KRW | -20.73B KRW |
| 2024 | 88.45B KRW | -14.57B KRW | -11.92B KRW |
| 2023 | 88.59B KRW | -5.97B KRW | -1.26B KRW |
| 2022 | 93.33B KRW | -2.12B KRW | -990.0M KRW |
| 2021 | 84.41B KRW | -4.31B KRW | -3.08B KRW |
Detailed financial statements for Dongsung Bio Pharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Dongsung Bio Pharm
The website of Dongsung Bio Pharm (dongsung-pharm.com) receives about 22.7K visits a month.
- Monthly visits22.7K
▲ 62.7% vs previous month
Websites whose visitors overlap most with Dongsung Bio Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hyundaipharm.co.kr | 100% | 25.8K | #1,103,659 | View details | |
kspder.or.kr | kspder.or.kr | 62% | #3,857,004 | β | |
| hkn24.com | 57% | #500,982 | View details | ||
taiguk.co.kr | taiguk.co.kr | 55% | #1,515,604 | β | |
medipana.com | medipana.com | 54% | #266,587 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 19 similar websites and full traffic analytics for Dongsung Bio Pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dongsung Bio Pharm
Dongsung Bio Pharm was founded in 1957.
Dongsung Bio Pharm is headquartered in Seoul, South Korea.
Lee Yang Gu is the CEO of Dongsung Bio Pharm, as recorded in our data.
Annual revenue of Dongsung Bio Pharm is $60.36M as on Dec 31, 2025.
Dongsung Bio Pharm was established in 1957 in Seoul, South Korea, within the pharmaceuticals and consumer goods sector. A range of over-the-counter and prescription medications is produced, alongside cosmetics, hair dyes, styling products, and health supplements. Various consumer items are also manufactured. Operations emphasize adherence to rigorous quality control standards across all production processes.
Dongsung Bio Pharm offers Web Hosting and Domain Management.
Yes, Dongsung Bio Pharm is publicly traded on KRX under the ticker symbol 002210.
Dongsung Bio Pharm operates through Gabia, Inc.